Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
VanEck Oil Services ETF
OIH
5
ProShares Ultra Energy
DIG
No Data
Puma Biotechnology Lifts Outlook Despite Q1 Setback
Puma Biotechnology's (NASDAQ:PBYI) Soft Earnings Are Actually Better Than They Appear
Puma Biotechnology Raises Outlook Despite Q1 Reset
TD Cowen Sticks to Their Hold Rating for Puma Biotechnology (PBYI)
Puma Biotechnology Non-GAAP EPS of -$0.04 Beats by $0.09, Revenue of $44.8M Beats by $2.8M
Puma Biotechnology | 10-Q: Q1 2026 Earnings Report